PTH synthesis and release under these conditions seems to be under a dual control: (1) hypercalcemia inhibits the synthesis and secretion of PTH from the parathyroid gland via activation of the CaSR and (2) active vitamin D3 suppresses the synthesis and release of PTH via activation of the VDR33. The gene discussed is CASR; the disease is hypercalcemia disease.